Treatment of autoimmune diseases

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

GERGELY PETER,WALLSTROEM ERIK

申请号：

NZ60399911

公开号：

NZ603999A

申请日:

2011.05.05

申请国别(地区):

NZ

年份:

2014

代理人:

摘要：

603999 Disclosed is the use of 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-propane-1,3-diol or the corresponding phosphate derivatives phosphoric acid mono-{ (S)-2-amino-4-[4-(3-benzyloxy-phenylsulfanyl)-2-chloro-phenyl]-2-hydroxymethyl-butyl} ester or phosphoric acid mono-{ (R)-2-amino-4-[4-(3-benzyloxy-phenylsulfanyl)-2-chloro-phenyl]-2-hydroxymethyl-butyl} ester, in the manufacture of a medicament for the treatment of scLE (Subacute Cutaneous Lupus Erythematosus).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/